Linked Life Data

9242897

Source:http://linkedlifedata.com/resource/pubmed/id/9242897

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-9-23
pubmed:abstractText
Traditionally, high-potency neuroleptics such as haloperidol have been used with success in the treatment of organic brain syndromes, but they have been associated with significant side effects such as EPS. We present the first case reports of a newer antipsychotic, risperidone, in the treatment of two delirious patients. Risperidone may prove to be an effective alternative to haloperidol in delirious patients, especially the elderly and the severely medically ill, who are more prone to adverse effects. Two case histories are presented, one of a 60-year-old man and the other of a 14-year-old boy in whom delirium was successfully treated with low doses of risperidone.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1040-1237
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
105-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Use of risperidone in delirium: case reports.
pubmed:affiliation
Department of Psychiatry, SUNY Health Science Center, Syracuse 13210, USA.
pubmed:publicationType
Journal Article, Case Reports